Med. Pro Praxi 2007; 1: 24-27

Jak správně poznat a léčit depresi

MUDr. Luboš Janů Ph.D, MUDr. Sylva Racková
Psychiatrická klinika FN a LF UK v Plzni

Deprese je jedno z nejčastějších onemocnění v primární péči. Je řídce diagnostikované, což má negativní dopady na úspěšnost léčby nejen deprese, ale i dalších onemocnění v populaci. Tento článek si klade za cíl stručnou a srozumitelnou formou podat prakticky využitelné informace o diagnostice, průběhu a léčbě depresivní poruchy. Je zaměřen na využití antidepresiv, jejich dávkování a případné nežádoucí účinky. Podpůrná psychoterapie a edukace pacienta by měly být nedílnou součástí léčby jakéhokoliv onemocnění. Lékaři primární péče, zejména praktičtí lékaři, jsou klíčem k úspěšné léčbě deprese.

Keywords: deprese, léčba, antidepresiva, primární péče

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janů L, Racková S. Jak správně poznat a léčit depresi. Med. praxi. 2007;4(1):24-27.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Psychiatric Association: Practice guideline for the treatment of patients with major depresive disorder, In Clinical Resources, www.psych.org.
    2. Boyer W. Serotinine uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: meta-analysis, Int Clin Psychopharmacol, 1995; 10: 45-49. Go to original source... Go to PubMed...
    3. Brady KT, Lydiard RB. The association of alcoholism and anxiety, Psychiatr Q, 1993; 64:135-149. Go to original source... Go to PubMed...
    4. Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta- regression analysis. Br J Psychiatry 2000;177:292-302. Go to original source... Go to PubMed...
    5. Furukawa TA, Streiner DL, Young LT: Antidepressant and benzodiazepine for major depression (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
    6. Geddes JR, et al. Selective serotonin reuptake inhibitors (SSRIs) for depression (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
    7. Janicak PG. Handbook of Psychopharmacotheraphy, Philadelphia, Lippincott Williams and Wilkins, 1999: 391.
    8. Kasper S, Zohar J, Stein DJ. Decision Making in Psychopharmacology. Martin Dunitz London, 2002; 165.
    9. Kennedy SH, Lam RW, Cohen NL, et al. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry (Canada), Jun 2001, 46 Suppl 1 p38S-58S.
    10. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM III-R psychiatric disorders in the United States, Arch Gen Psychiatry, 1994; 51: 8-19. Go to original source... Go to PubMed...
    11. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disordersit the United States: using a clinical significance criterion to reconsile 2 surveys´ estimates, Arch Gen Psychiatry, 2002, 59: 115-123. Go to original source... Go to PubMed...
    12. Seifertová D, Praško J, Hoschl C: Postupy v léčbě psychických poruch, Praha, Academia Medica Pragensis, 2004; 139-251.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.